Insider plans $2.45M sale of Procter & Gamble stock

The Procter & Gamble Company investor files a notice to sell restricted shares under Rule 144.

Rhea-AI Filing Summary

The Procter & Gamble Company investor files a notice to sell restricted shares under Rule 144. The planned transaction covers 15,169 shares of common stock with an aggregate market value of $2,448,124.91, to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

The shares were acquired and paid for in cash on 02/13/2026 through an exercise and sale of stock options. The filing also notes that Procter & Gamble had 2,324,000,685 shares of common stock outstanding, providing context for the size of this proposed sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for PG disclose?

The Form 144 filing discloses an intended sale of 15,169 Procter & Gamble common shares under Rule 144. The proposed sale has an aggregate market value of $2,448,124.91 and is to be executed on the NYSE through Morgan Stanley Smith Barney LLC.

How many Procter & Gamble (PG) shares are planned for sale in this Form 144?

The notice covers an intended sale of 15,169 shares of Procter & Gamble common stock. These shares have an aggregate market value of $2,448,124.91 and are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, according to the filing details.

How were the Procter & Gamble (PG) shares in the Form 144 acquired?

The 15,169 Procter & Gamble shares were acquired on 02/13/2026 via an exercise and sale of stock options. The filing states that the purchase price was paid in cash on the same date, aligning the acquisition and proposed sale with a single transaction event.

What is the aggregate market value of the PG shares in this Form 144?

The aggregate market value of the 15,169 Procter & Gamble common shares covered by the notice is $2,448,124.91. This value is based on the filing’s securities information table and reflects the total market worth of the shares proposed for sale under Rule 144.

Which broker will handle the Form 144 sale for Procter & Gamble shares?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 38th Floor, New York, NY 10004, and the shares are expected to be sold on the NYSE, as specified in the filing.

What does the Form 144 say about Procter & Gamble shares outstanding?

The filing notes that Procter & Gamble had 2,324,000,685 shares of common stock outstanding. This figure provides context for the scale of the 15,169 shares proposed for sale, showing the intended transaction is small relative to the company’s total share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 06:50 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001825382
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCTER & GAMBLE Co
SEC File Number	001-00434
Address of Issuer	ONE PROCTER & GAMBLE PLAZA CINCINNATI OHIO 45202
Phone	5139831100
Name of Person for Whose Account the Securities are To Be Sold	Aguilar Moses Victor Javier
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	15169	2448124.91	2324000685	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/13/2026	Exercise and Sale of Stock Option	The Procter & Gamble Company			15169	02/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	1) Based on the average high and low price on February 12, 2026. 2) Acquisition and payment dates for stock option exercise will be the same.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wednesday Shipp, attorney-in-fact for Victor J. Aguilar Moses
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)